Vincristine as an Adjunct to Therapeutic Plasma Exchange for Thrombotic Thrombocytopenic Purpura: A Single-Institution Experience


Creative Commons License

Ongoren S. , Salihoglu A., Apaydin T., Sadri S., Eskazan A. E. , Ar M. C. , ...Daha Fazla

BALKAN MEDICAL JOURNAL, cilt.35, ss.417-421, 2018 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 35 Konu: 6
  • Basım Tarihi: 2018
  • Doi Numarası: 10.4274/balkanmedj.2017.1215
  • Dergi Adı: BALKAN MEDICAL JOURNAL
  • Sayfa Sayıları: ss.417-421

Özet

Background: Thrombotic thrombocytopenic purpura is a potentially life-threatening condition. Although the introduction of therapeutic plasma exchange has reduced mortality rates from over 90% to 10%-20%, approximately 40% of patients relapse, and outcomes may be fatal in refractory patients. There is clearly a need for additional therapeutic approaches.